PTU-001 Tofacitinib, an oral jak inhibitor, in the treatment of ulcerative colitis: open-label, long-term extension study

2018 ◽  
Author(s):  
Stuart Bloom ◽  
Gary R Lichtenstein ◽  
Edward V Loftus ◽  
Nervin Lawendy ◽  
Gary S Friedman ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Extension Study ◽  
Jak Inhibitor ◽  
Open Label

Long-Term Effectiveness and Safety of Vedolizumab in Patients with Ulcerative Colitis: 5-Year Cumulative Exposure of Gemini 1 Completers Rolling into the Gemini Open-Label Extension Study

2017 ◽  
Vol 152 (5) ◽  
pp. S602 ◽  
Author(s):  
Edward V. Loftus ◽  
Jean Frederic Colombel ◽  
Brian G. Feagan ◽  
Severine Vermeire ◽  
William J. Sandborn ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Cumulative Exposure ◽  
Extension Study ◽  
Open Label ◽  
Open Label Extension

Tu1874 MAINTENANCE OF REMISSION WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: UPDATED RESULTS OF A SUBPOPULATION ANALYSIS FROM AN OPEN-LABEL, LONG-TERM EXTENSION STUDY, OCTAVE OPEN

2020 ◽  
Vol 158 (6) ◽  
pp. S-1198-S-1199
Author(s):  
Jean Frederic Colombel ◽  
Mark T. Osterman ◽  
Patricio Ibanez ◽  
Andrew J. Thorpe ◽  
Haiying Zhang ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Extension Study ◽  
Open Label ◽  
Maintenance Of Remission
Sign in / Sign up

Export Citation Format

Share Document